These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3358099)

  • 1. Apolipoprotein E in hepatocellular liver disease.
    Florén CH
    Scand J Clin Lab Invest; 1988 Apr; 48(2):199-203. PubMed ID: 3358099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [THE LIPOLYSIS IN PHYLOGENETICALLY EARLY LIPOPROTEINS OF LOW DENSITY AND MORE LATER LIPOPROTEINS OF VERY LOW DENSITY: FUNCTION AND DIAGNOSTIC VALUE OF APOE AND APOC-III].
    Rozhkova TA; Titov VN; Amelyushkina VA; Kaba SI; Kukhartchuk VV
    Klin Lab Diagn; 2015 Dec; 60(12):4-14. PubMed ID: 27032246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2.
    Dashti N; Wolfbauer G
    Biochim Biophys Acta; 1986 Feb; 875(3):473-86. PubMed ID: 3004589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human triglyceride-rich lipoprotein apo E kinetics and its relationship to LDL apo B-100 metabolism.
    Millar JS; Lichtenstein AH; Ordovas JM; Dolnikowski GG; Schaefer EJ
    Atherosclerosis; 2001 Apr; 155(2):477-85. PubMed ID: 11254920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the metabolism of very-low- and low-density lipoproteins after partial ileal-bypass surgery in the Watanabe heritable hyperlipidaemic rabbit.
    Mol MJ; Stalenhoef AF; Demacker PN; van 't Laar A
    Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):651-7. PubMed ID: 1898354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of nascent lipoproteins produced by perfused rat liver: evidence of hepatic secretion and post-secretory modification of nascent lipoproteins.
    Teramoto T; Watanabe T; Matsushima T; Horie Y; Oka H
    J Biochem; 1990 Apr; 107(4):519-25. PubMed ID: 2358425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.
    Fan J; Ji ZS; Huang Y; de Silva H; Sanan D; Mahley RW; Innerarity TL; Taylor JM
    J Clin Invest; 1998 May; 101(10):2151-64. PubMed ID: 9593771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
    Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
    van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
    Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E in alcoholics.
    Wehr H; Bednarska-Makaruk M; Szacka E
    Alcohol Alcohol; 1995 Jan; 30(1):27-30. PubMed ID: 7748272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dietary monounsaturated fatty acids on lipoprotein concentrations, compositions, and subfraction distributions and on VLDL apolipoprotein B kinetics: dose-dependent effects on LDL.
    Gill JM; Brown JC; Caslake MJ; Wright DM; Cooney J; Bedford D; Hughes DA; Stanley JC; Packard CJ
    Am J Clin Nutr; 2003 Jul; 78(1):47-56. PubMed ID: 12816770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids.
    Angelin B; Raviola CA; Innerarity TL; Mahley RW
    J Clin Invest; 1983 Apr; 71(4):816-31. PubMed ID: 6300188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E-containing lipoproteins and lipoprotein remnants in experimental canine diabetes.
    Wilson DE; Chan IF; Elstad NL; Peric-Golia L; Hejazi J; Albu DS; Cutfield R
    Diabetes; 1986 Aug; 35(8):933-42. PubMed ID: 3732634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein A-I in liver disease.
    Florén CH; Franzén J; Albers JJ
    Scand J Gastroenterol; 1987 May; 22(4):454-8. PubMed ID: 3110938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of total lipids, cholesterol, lipoproteins and apolipoprotein A in the blood of subjects with acute hepatitis and chronic hepatopathy].
    Vergani C; Trovato G; Pietrogrande M; Crocchiolo P; Dioguardi N
    Minerva Med; 1978 Jun; 69(31):2081-94. PubMed ID: 208025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the lipid profile in chronic hepatopathies].
    Perales J; Angel Lasunción M; Cano A; Martín-Scapa MA; Matíes M; Herrera E
    Med Clin (Barc); 1994 Mar; 102(10):364-8. PubMed ID: 8182981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.